Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19
Glenda Canderan, Lyndsey M. Muehling, Alexandra Kadl, Shay Ladd, Catherine A. Bonham, Claire E. Cross, Sierra M. Lima, Xihui Yin, Jeffrey M. Sturek, Jeffrey M. Wilson, Behnam Keshavarz, Kyle B. Enfield, Chintan Ramani, Naomi Bryant, Deborah D. Murphy, , Judith A. Woodfolk
The paper identifies distinct type 1 immune networks associated with varying severities of restrictive lung disease following COVID-19.
Nature Immunology · Mar 26, 2025Peer-reviewedImmunology